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ABSTRACT
BOVINE CELLULAR AND INNATE IMMUNE RESPONSE TO
HEMOSTATIC POLYSACCHARIDES
BRIAN KOBYLKEVICH
2019
Chronic wounds are longstanding dermal wounds that do not heal in a normal
amount of time and can commonly last for over a year. These wounds plague humans and
farm animals alike. Wounds are characterized by chronic inflammation and are often
painful, difficult to heal, have a high recurrence rate, and are potentially debilitating. Long
term wounds that do not fully heal are distressing for both humans and animals, but
understandably more resources have been directed towards humans. Some treatment
options for humans may be suitable for adaptation into the field of animal care. Chronic
lesions such as bovine digital dermatitis (BDD), sole ulcers, and foot rot might be treated
using proven techniques from human medicine. BDD is a chronic wound, characterized by
poly-microbial infection of the hoof that is highly transmissible between cattle. BDD has
been reported to greatly impact milk production in dairy herds, result in lameness, and
require potentially costly preventative and/or treatment methods.
Polysaccharide bandages, currently used to stop hemorrhaging in humans, serve as
a potential treatment for chronic wounds. Oxidized regenerated cellulose (ORC) and chitin
or chitosan, are effective hemostatic bandages that are being explored to promote wound
healing. These novel materials promote some beneficial effects in human wounds but our
knowledge of their effects on other mammals is nearly non-existent.

x
We have examined the innate immune response of bovine dermal cells to these
polysaccharide hemostats. Polysaccharide materials were characterized with cross
polarization-nuclear magnetic resonance (CP-NMR) prior to experimentation. The innate
immune response of bovine fibroblasts was monitored by measuring mRNA expression of
select cytokines and Toll-like receptors after exposure to ORC and chitin for 24 hours. The
roles of ORC and chitin on the lipopolysaccharide (LPS) induced inflammatory response,
and fibroblast viability were also determined The results demonstrated that both ORC and
chitin elicit a relatively weak immune response from the fibroblasts, reduce expression of
inflammatory cytokines in response to LPS, and do not increase mortality at the
concentrations used. In conjunction with other previously characterized properties these
polysaccharides may improve the healing of chronic epidermal wounds in humans and
farm animals.
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INTRODUCTION
Persistent, chronic wounds have become a major cost in both animal and human
health. Chronic wounds are those that do not heal or resolve within a month and are present
in both humans and animals. Chronic wounds can be persistent due to chronic
inflammatory signaling. Bed sores are a commonly known human example, where less
mobile and/or bed confined patients develop epidermal ulcers that can take months to fully
resolve. Chronic inflammatory wounds such as bed sores and pressure ulcers have
undergone novel solutions in humans, including the use of new polysaccharide bandages.
Human solutions could be adapted and applied toward animal chronic wounds to offer
more options for treatment and prevention of these wounds.
Livestock animals such as sheep, pigs, goats, chickens, turkeys, and cattle suffer
from wounds that are analogous to chronic wounds in humans. Bovine in particular have
volumes of research calculating the cost of such wounds in both treatment and production
losses [2]. Injuries such as foot rot, sole ulcers and bovine digital dermatitis (BDD) impact
fertility rates and milk production significantly and represent inflammatory lesions that can
endure for long periods of time. Just to look at one example, BDD is a major concern
among both dairy and beef herd managers as it impacts profit margins and is considered
by common veterinary manuals, at the time of writing, to be impossible to truly eliminate
once present in a herd [3, 4]. The difficulty of treating BDD is partially due to the
polymicrobial nature of the infection, with multiple microbe genera contributing to the
infection. Preventative sanitation methods and antimicrobial administration are the major
means of managing infections among herds.
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Bovine rearing has retained its place as a major source of revenue among the variety
of agricultural industries in the United States. United States dairy exports were valued at
$5.6 billion in 2018, with that volume representing only 15.8 percent of the total production
volume of the United States dairy industry for that year [5]. Similarly, beef exports have
been valued considerably, reaching $8.3 billion in 2018. Bovine digital dermatitis can
impact both industries as infections can induce lameness, reduce fertility, and lower milk
production.
In the United States the average cost per case of BDD in dairy cows is estimated to
be about $133 [6], with national costs soaring to $190 million in 2006 [7]. The largest
contribution to the cost is the expense of treatment for a BDD wound, forming 46% of the
cost, with the rest of the costs coming from production losses in fertility and milk [6]. The
average US dairy herd size has been steadily increasing over the past 20 years. In 2018 the
national dairy herd size averaged 251 cows, a 7.2% increase compared to 2017, with herd
sizes in the American South-West averaging 1,343 cows per herd [8]. With estimated
prevalence varying from 22-26% among American free-stall dairy herds [9], and the
increasing size of herds year to year, BDD represents a major impact to future production
for dairy farms. The possible hinderance to the dairy industry has spurred much research
about the pathology, treatment options, preventative measures and methods of detection.
It is important to note that BDD has many research articles emanating from vastly
different regions of the world. Some publications conclude genetics play some role in the
vulnerability of bovine to BDD [10]. Other research articles show the effects of farm and
herd management on the incidence rate among herds [11], while others show evidence of
microbiome shifts in specific bacterial populations that influence the infectious stages [1,
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9]. This introduction seeks to represent the range of supported observations of the scientific
community, at the time of writing, to provide as complete a view of the issue as possible.

Bovine Digital Dermatitis Etiology
Bovine digital dermatitis is a polymicrobial disease, first noticed in Italy in 1976
[12]. It has since been reported across the globe and is reported as a major cause of
lameness in dairy herds, with especially high prevalence in intensively managed dairy
herds [3]. BDD manifests as a lesion, usually on one or both hind feet, appearing as either
an erosive or a proliferative wart-like wound.
BDD lesions have a classification scale based on the phase of healing, Figure 1.
The M0 stage is normal, healthy skin. The M1 stage precedes the acute phase of infection,
with a lesion <2 cm in diameter that looks like either a red or grey epithelial defect. The
M1 stage is normally seen between acute phases of infection. M2 lesions are acute, with
granulomatous (red-grey) or ulcerative (“strawberry”) colored wounds >2 cm in diameter,
occasionally with a surrounding set of white, potentially papillomatous, tissue. M3
describes lesions that are in the healing phase, characterized by a stiff scab, generally seen
1-2 days after topical treatment. M4 is considered a chronic infection stage, with thickened
epithelia and/or proliferation, with a filamentous or scab-like surface several centimeters
in diameter. M4.1 is considered a combination of the effects of M1 and M4 lesions, having
a grey or red area of epithelial defects and a large section of thickened and/or proliferative
skin.
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Figure 1: Representative photos of the different BDD wounds. Wound severity increases
with M1, M2 and M4. M3 is a recovering wound and M4.1 has the appearance of M1 and
M4 wounds. Image: [1]

Common BDD Treatment
Current treatment options for these bovine digital dermatitis lesions are limited to
topical treatments of antibiotic powders such as oxytetracycline or extremely high
parenteral doses of antibiotics. In published research articles, topical treatments of
oxytetracycline have been the most promising treatment option for resolving BDD lesions
[13-15]. Some researchers have made note that oxytetracycline treatments have reduced
wound size but have left lesions in “pre-clinical” states of infection [9].
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Preventative measures include regular power washing of feet with soapy water,
medicated foot baths, and ensuring that the environment is free of fecal slurry. Footbaths
are especially effective in large herds where BDD is often most prevalent and individual
washing of cow feet would be time and labor-intensive. The use of foot baths relies on
chemical antiseptics such as formalin solutions or antibiotic solutions [3]. Both types of
bath liquid involve hazardous materials that need to be disposed of in special manners. In
the future, and depending upon the nation of residence, some bath cleaning solutions may
require specialized disposal and removal by tanker truck, adding to preventative costs.
Another preventative measure is termed ‘biosecurity’, referring to a quarantine protocol
for incoming bovine to prevent the potential spread of BDD, especially associated with
more pathogenic strains of microbes.
While many bacteria are present in BDD wounds, treponemes have been
consistently identified and appear to be an important pathogen in the wound [16-18]. These
treponeme bacteria are spiral shaped, with an internal flagellum that rotates inside the cell,
effectively turning the organism into a motile corkscrew that can travel through fluids.
They are generally anaerobic or microaerophilic bacteria, preferring the low-oxygen
environments of deep tissue wounds. These bacteria are found commonly in the wounds,
but are not present in typical, healthy skin flora of bovine. These treponemes were once
thought to be the bacteria initiating the infections [19], however, now they are considered
important agents but not wholly responsible for different phases of the infection. Their
importance and relevance is supported by the wide range of published research
documenting the same species and subspecies in BDD lesions and the shifts in the number
and types of treponemes in the wider bacterial population within lesions [1, 17, 18, 20].
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Many of these treponeme species are linked to the fecal-oral route of bovine,
residing at some point within the route. This can complicate the idea of “eradicating” the
infections from the herd because the cow’s rumen and intestinal tract can serve as reservoirs
for these pathogens. Even clearing lesions of treponemes can be quite challenging with
current treatment options. The single application of topical tetracycline can lead to
recurring infections of BDD at relatively high rates of 44% when followed for time frames
of greater than 50 days [9]. While oxytetracycline is still the most widely accepted
treatment option, the rate at which BDD lesions recover back to normal skin standards
ranges from 9-39%. Even when less stringent qualifiers are used and researchers just look
for a decrease in BDD lesion size or pain in the cow, success rates range from 47-73% [14,
21-23]. Combining the unique situation of the cows being a potential reservoir for the very
pathogens that threaten them and the extreme difficulty of truly eradicating the bacteria
from anaerobic wounds gives insight to the motivation for alternative treatments and
preventative measures.

Polysaccharide Bandages
An alternative antimicrobial and anti-inflammatory material might help treat BDD
and other epidermal wounds of livestock. Increasing numbers of bandages are made with
biodegradable materials, including linear chain polysaccharides. Two of these
polysaccharides are oxidized regenerated cellulose (ORC) and chitin. ORC, is a
polysaccharide of glucose condensed through β(1→4)-linkages, in which glucose has been
oxidized to glucuronic acid, to varying degrees, in order to improve biodegradation [24],
Figure 2. Chitin is a biodegradable polymer of N-acetylglucosamine, also condensed
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through β(1→4)-linkages, and commonly used as chitosan, a polymer with a lower degree
of acetylation than chitin [25, 26], Figure 2. Both polysaccharides are used as rapid
hemostatic agents [27-30], but they are finding their way into bandages to improve the
healing of chronic wounds [31, 32]. However, both polysaccharides have properties that
may preclude their use as wound healing agents.

Figure 2: ORC, Chitin, and chitosan are comprised of a glucose backbone. Oxidized
regenerated cellulose is a polymer of irregularly spaced glucose and glucuronic acid
residues. Chitin is a polymer of N-acetylgluosamine. A dimer is shown for comparison
with ORC and chitosan. Chitosan is a deacetylated form of chitin with irregularly spaced
N-acetylgluosamine and glucosamine residues.
ORC appears to possess superior properties for rapid blood clotting compared to
other polysaccharides [27]. It possesses antimicrobial properties in vitro [33, 34] and in
vivo [35]. Biodegradation of ORC occurs through fiber hydrolysis in the presence of serum
[36] and when implanted in vivo [37]. The degradation rate is increased in response to
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serum compared to NaOH or PBS, supporting the role of enzymatic hydrolysis [36].
However, ORC also attracts immune cells, supporting the conclusion that in vivo
degradation also depends on cell-mediated degradation [37]. While many articles report
few complications with the application of external ORC [38], other reports indicate that
internal use of ORC leads to the formation of abscesses and granulomas [39-41]. Therefore,
advice has been given to remove the material from regions surrounding neurons or where
swelling and compression of tissues could pose secondary health risks [42]. In addition to
activating an immune or foreign body response, ORC has been reported to impair fibroblast
proliferation and migration [43]. These features may limit the use of ORC as a bandage for
wound healing.
Chitin with the highest degree of acetylation, i.e. poly-N-acetyl glucosamine, or
chitosan that has been modified with hydrophobic groups, possess more rapid hemostatic
properties compared to chitosan alone [29, 44]. Chitin, chitosan and chitinoligosaccharides can inhibit bacterial and fungal growth directly [45-47], while indirectly,
chitin appears to elicit release of antimicrobial peptides from eukaryotic cells [48]. Many
endogenous enzymes are capable of hydrolyzing chitin [47, 49]. In vivo, chitin activates an
immune response to attract cells that promote its degradation [25, 50]. The higher the
degree of acetylation, the faster the degradation of the chitin polymer in vivo [26]. Higher
degrees of acetylation lead to more rapid degradation in vitro and in vivo [51, 52].
Macrophages possess a size-dependent response to chitin. Large chitin particles from
shrimp shell (70-100 µm) are inert, intermediate chitin (40-70 µm diameter) promotes an
inflammatory response and small chitin (2-10 µm) promotes release of both inflammatory
and anti-inflammatory mediators [53, 54]. Therefore, chitosan and intermediate sized
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particles of chitin may not be easily degraded and may promote significant inflammatory
responses that impair wound healing.

Inflammatory Signaling
Cytokines are proteins secreted by cells that elicit responses from cells. Cytokines
can act as signaling molecules between similar cells or between different cell types and can
have systemic or local impacts. Cytokines cover a wide range of different messages
between cells, with some cytokines like interleukin 6 (IL-6) having different effects in
different tissues. IL-6, in particular, can act as a pro-inflammatory cytokine or as an antiinflammatory cytokine depending upon the tissue by stimulating production of the classical
anti-inflammatory cytokines IL-10 [55] & IL-1 receptor agonist (IL-1ra), which
competitively inhibits IL-1 receptors [56]. Cytokine signaling can change based on cell,
tissue and organism, so general trends among cytokines such as IL-10, which is broadly
considered anti-inflammatory, are often considered when monitoring cytokine production
in uncharacterized cells, tissues or organisms. Table 1 displays generally accepted effects
of certain cytokines and their broad effect regarding inflammation.
Table 1: Summary table of cytokine effects and inflammatory responses.
Cytokine

Inflammatory Response

Interleukin 1 α

Pro-inflammatory

Interleukin 1 β

Pro-inflammatory

Interleukin 6
Interleukin 8

Pro-inflammatory
(macrophage + fibroblast)
Pro-inflammatory

Interleukin 10

Anti-inflammatory

Tumor Necrosis Factor α

Pro-inflammatory
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Toll like receptors (TLRs) are membrane-bound receptor proteins that recognize
structurally conserved domains of damage-associated molecular patterns (DAMPs) and/or
pathogen-associated molecular patterns (PAMPs). These receptors bind to substances that
are associated with microbial infection or local cell death, such as microbial LPS or
intracellular heat shock proteins from a neighboring cell. When bound to a recognized
PAMP or DAMP, TLRs start a signaling cascade that can activate transcription factors that
will change gene expression, such as nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB). All TLR signaling pathways activate NF-κB through the relative
rapid action of kinase phosphorylation rather than slower methods such as protein synthesis
[57]. Once activated NF-κB can alter gene expression of genes responsible for both innate
and adaptive immune responses, with inflammatory cytokines often a target [58]. TLRs are
integral receptors that shape the immune response and inflammatory signaling pathways in
response to potential threats. Table 2 lists some TLRs, the PAMPs and DAMPs that
activate them, and the products of TLR activation.
Chronic epidermal wounds are commonly associated with increased inflammation
[59, 60]. Therefore, introduction of materials that promote further inflammation could be
a complication. BDD is characterized by loss of outer epidermal layers, inflammation and
microbial infection including multiple treponeme species [61]. Bovine fibroblasts and not
keratinocytes appear to be the major contributors to inflammation in BDD lesions [62].
Therefore, we have explored the response of primary bovine dermal fibroblasts to these
two polysaccharides, including viability, immune response and the role of the
polysaccharides in blocking the immune response to microbial lipopolysaccharide. In order
to avoid the immune response to particles of chitin [53, 54] we have explored the role of
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chitin nanofibers with dimensions of 100 µm by 0.5 µm [63] and compare it to the response
of commercially available ORC.

Table 2: Summary table of TLRs, their DAMP and PAMP elicitors, and products.
TLR
PAMPs
TLR1 + Triacylated lipoproteins
TLR2 (Peptidoglycans, Lipopolysaccharides)

TLR2 +

(TLR2 DAMPs listed
below)

IC

•

Heat Shock Proteins
(HSP 60, 70, Gp96)
High mobility group
proteins (HMGB1)
Proteoglycans
(Versican, Hyaluronic
Acid fragments)

IC

•
•

mRNA
tRNA

IC,
type1 IFN

•

Heat Shock Proteins
(HSP22, 60, 70,72,
Gp96)
High mobility group
proteins (HMGB1)
Proteoglycans
(Versican, Heparin
sulfate,
Hyaluronic Acid)
Fibronectin,
Tenascin-C

IC,
type1 IFN

•
•

dsRNA (poly (I:C))
tRNA, siRNA

•
TLR4

Lipopolysaccharides (LPS)
Paclitaxel

•

•
•
TLR5
TLR7
TLR8
TLR9

Flagellin
ssRNA
Imidazoquinolines
Guanosine analogs
ssRNA,
Imidazoquinolines
CpG DNA
CpG ODNs

Production

•

Diacylated lipoproteins

TLR6

TLR3

DAMPs

IC
•

ssRNA

•

ssRNA

•

IC,
type1 IFN

IC,
type1 IFN
IC,
Chromatin IgG complex
type1 IFN
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MATERIALS AND METHODS
Polysaccharide Analysis
Cross polarization nuclear magnetic resonance (CP-NMR) was used to characterize
the relative oxidation state of ORC and the level of acetylation of the chitin nanofibers.
ORC, BenaCel with no chemical additives, was obtained from Unicare Biomedical
(Laguna Hills, CA). Chitin nanofibers were provided by John Vournakis (Marine Polymer
Technologies, Burlington, MA). The 13C CPMAS NMR spectra were measured using a
Bruker Avance spectrometer (Billerica, MA) and 4BL MAS NMR probe at 75.5 MHz (7.05
Tesla) using continuous wave decoupling, while the sample was spinning at 9.0 kHz. The
spectral width measured was 25.0 kHz. A recycle delay of 4 seconds was used and 18,000
scans were accumulated for each spectrum. The acquired free induction decays were
baseline corrected, multiplied by an exponential corresponding to 10 Hertz of line
broadening and then Fourier transformed and phased. The chemical shifts were referenced
to an external sample of glycine with the carbonyl resonance set to 177 ppm.

Bovine Fibroblast Extraction
Bovine skin was obtained from neck and shoulder regions of euthanized animals
that were less than 30 months old (SDSU meat lab). Skin was transported in an aseptic
container on ice and placed in a sterile culture hood. The external side of the skin segment
was sprayed with 70% ethanol and wiped to help clear debris caught between hairs and
reduce bacterial load. The hair was then shaved off using an electric hair trimmer and the
external surface of skin sections was sprayed again with 70% ethanol. Sterile dissection
blades (Razor Blade Co., Van Nuys, CA 91411) were then used to trim away underlying
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fat and connective tissue on the internal side of the skin. After removal of underlying
connective tissue, the dermis is cut into thinner strips, approximately 0.5 by 2 cm, with
sterile scissors and submerged in an enzyme digest medium for 2 hours at 37 ℃ with
occasional mixing. The enzyme mixture was comprised of Dispase II (0.15 units/ml)
(Roche, Indianapolis, IN), 2 mg/ml collagenase, 1% penicillin streptomycin 10 KIU, 0.05
mg/ml of trypsin inhibitor (Sigma-Aldrich, Saint Louis MO), and DMEM media (Gibco,
Grand Island NY) to a final volume of 25 ml. Afterwards, the skin sections were further
nicked along the edges to increase surface area, and rinsed with divalent-free saline before
being incubated at 37 ℃ on a rocker for 45 minutes in divalent-free, low protein DMEM.
The calcium-free DMEM was discarded and 0.25% trypsin (Gibco, Grand Island NY) was
used to loosen cells from the main mass of the skin strips. Trypsin was removed after 15
min, diluted using 10% FBS DMEM, and cells were concentrated using a swinging bucket
centrifuge (Sorvall RC3B, Newtown CT) at 220 x g.

Bovine Fibroblast Cell Culture
Fibroblasts were cultured in collagen-coated 25 cm2 flasks (Corning, Kennebunk
ME) with 10% FBS DMEM. Cells cultured on collagen showed the greatest initial
retention and survival after isolation. After 24 hours media was changed to remove any
dead or floating cells. Once cells in the initial collagen-coated flask were split they were
cultured in standard tissue culture plastic. In the case of all bovine samples, fibroblasts
overwhelmed the plate, growing faster than other cell types, and representing the majority
of cells that initially adhered to the flask. Within 1-2 passages the flasks are highly enriched
in fibroblast population. With subsequent passages, flasks displayed greater fibroblast
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enrichment, to the extent that over 95% of the population was fibroblasts. After two weeks
in culture, cells were frozen and stored in liquid N2 in 10% DMSO, in DMEM with FBS.
Prior to experiments, cells were grown to approximately 80-90% confluency,
before the media was changed to a serum free medium, Medium 154 (Gibco, Grand Island
NY), for 24 hours. Serum free medium was used to reduce potential irregular, non-specific
signaling of cells by the FBS. After the 24-hour resting period, media was exchanged with
Medium 154 containing nothing (control), an inflammatory elicitor (LPS), or
polysaccharides (oxidized regenerated cellulose or chitin nanofibers). The polysaccharides
were added to Medium 154 at concentrations of 2 mg/ml and 5 mg/ml, while the final
concentration of LPS (Sigma-Aldrich, Saint Louis MO) was 1 µM. DMSO at a final
concentration of 0.1% was used to promote solubilization of LPS. ORC fibers were highly
soluble, even at 5 mg/ml, but the chitin nanofibers were never fully soluble and generated
much greater viscosity when placed in solution.

Immunocytochemical (ICC) staining of primary cells
Monoclonal antibodies (mAbs) raised against cytokeratin (epithelial cell marker)
and vimentin (fibroblast marker) were used to stain primary cells. Cells cultured in T-25
or T-75 flasks were treated with 0.05% Trypsin EDTA and counted using a hemocytometer
in order to prepare a suspension of 106 cells/ml of primary bovine fibroblasts. A small
sample of the suspend cells, 100 µL, was used to prepare cytospin slides using a cytofuge
(Cytospin 3; Thermo Shandon Inc. Pittsburgh, PA,). After air drying for 2 hours, the cells
were fixed on the slides in acetone for 7 minutes. Slides were then washed with 1% PBS.
Endogenous peroxidase was blocked using a 7 min. incubation in blocking solution
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consisting of 0.3% hydrogen peroxide and 0.01% sodium azide in PBS. In order to prevent
further non-specific antibody binding, slides were incubated with 1% goat serum for 20
minutes. An avidin-biotin blocking kit (Vector Laboratories, #SP2001 Burlingame, CA,
USA) was used to block endogenous biotin. Specific mAbs were used to detect the
presence of cytokeratin and vimentin proteins by immunocytochemistry. Anti-cytokeratin
mAb C6909 (IgG2a isotype) and anti-vimentin mAb V5255 (IgM isotype) were used in
addition to corresponding isotype-matched controls, mAbs M9144 (IgG2a isotype) and
196 M5170 (IgM isotype). Cells incubated with PBS alone served as a negative control.
All primary and isotype control mAbs were bought from Sigma-Aldrich (Sigma-Aldrich,
St. Louis-MO). Slides were incubated for an hour with 100 µl (1 µg/ml) of the specific
primary antibody or isotype controls. Slides were then washed and incubated with 100 µl
(1:2000 dilution) of isotype-specific, biotinylated goat-anti mouse IgG2a, IgG1, and IgM
antisera (Caltag Laboratories) for 30 minutes. Presence of specific protein in the fibroblasts
was detected by incubating slides with the HRP-streptavidin solution for 30 min, followed
by ready-to-use diaminobenzene (DAB) substrate (Vector Laboratories, Burlingame, CA,
USA). Hematoxylin was used as a nuclear stain. Images were acquired using an Olympus
BX53 upright microscope at 20X magnification and a digital camera.

qPCR
After 24 hours of exposure to elicitors and polysaccharides, RNA was extracted
from cells (RNeasy RNA Extraction Kit; Qiagen, Hilden Germany) and mRNA was
converted to cDNA (First Strand DNA Synthesis kit; New England Biolabs, Ipswich MA).
qPCR primers (Integrated DNA Technologies Inc., Coralville Iowa) and SYBR Green
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mastermix (Qiagen, Germantown Maryland) were used in a QuantStudio 6 qPCR machine
(Applied Biosystems, Waltham MA) in the Genomics Core Facility (McFadden BioStress,
SDSU) to determine relative mRNA concentration. qPCR targets included bovine TLR 19, Beta Actin, interleukin-1 (IL-1) alpha, IL-1 beta, IL-6, IL-8, IL-10, and tumor necrosis
factor (TNF) alpha [64]. The qPCR protocol remained the same over all repetitions. The
initial phase temperature ramp was 50 ℃ for 2 minutes, with a 1.6 ℃/second increase to
95 ℃, then held for 5 minutes. The cyclical phase temperature ramp was held at 95 ℃ for
45 seconds, decreased to 60 ℃ and held for 30 seconds, then increased to 72 ℃ and held
for 30 seconds before repeating.

Cell Viability Assay
Bovine fibroblasts were cultured in a 96 well plate (Corning, NY 14831) using
culture media and methods as described above. Polysaccharides were added to the cells
after being solubilized in a phenol red-free variant of the FBS DMEM at 2 mg/ml and 5
mg/ml concentrations. At 24 hours after the addition of the polysaccharide media
propidium iodide (Acros Organics, NJ) was added to a final concentration of 30 µM and
incubated at 37℃ for 1 hour. Three images were taken per well at different locations on an
Olympus Fluoview FV1200 laser scanning confocal microscope system interfaced with an
IX81 microscope. After initial readings, 6% triton-x100 was added to a final concentration
of 0.85% to expose the nucleus of all cells and cells were incubated for an additional hour
prior to a second imaging session. The two step propidium iodide stain enabled
identification of dead cells and then all cells in a well to determine whether the
polysaccharides promoted cell death.
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RESULTS
The specific chemical nature of the two polysaccharides was characterized by
measuring the 13C content using CP-NMR [65, 66]. The percent acetylation of the chitin
nanofibers was determined by comparing the relative intensities of the resonances of the
carbons in the glucose ring (C1-C6) with the methyl carbon, ~20 ppm, according to [67].
The ratio indicates that the chitin nanofibers are 96% acetylated, Figure 3 upper trace, or
nearly fully acetylated as described previously [68]. The percent oxidation of the cellulose
in the ORC bandage was determined in a similar manner comparing the relative intensity
of the carboxyl carbon, ~180 ppm, with the other glucose carbons [65]. The ORC bandage
possesses 38% glucuronic acid, Figure 3 lower trace, or nearly 62% cellulose.
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Figure 3: Cross Polarization NMR spectra of chitin nanofibers and ORC. The spectra
display a high degree of acetylation in the chitin sample, and partial oxidation in the ORC
sample.
In order to confirm the identity of the primary cells from the bovine dermal cultures,
cells were thawed from liquid N2 stocks and grown for one passage and stained for
keratinocyte and fibroblast markers. Immunocytochemistry staining indicates that the
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enriched dermal cells stain negatively for cytokeratin, Figure 4A and positively for
vimentin, Figure 4B. Each protein is an established marker for bovine keratinocyte and
fibroblast cells, respectively [69].
A

B

Figure 4: Bovine fibroblasts stain positively for vimentin but not cytokeratin. A) A sheet
of fixed bovine fibroblasts does not stain with cytokeratin antibody. B) A second sheet of
bovine fibroblasts from the same culture stain with a vimentin antibody.
In order to determine the innate immune responses of fibroblasts to ORC or chitin
nanofibers we extracted and studied bovine fibroblasts, from three different animals.
Changes in expression of selected cytokines and toll-like receptors (TLRs) were used so
the responses of bovine fibroblasts could be compared to other cell lines that were exposed
to similar polysaccharides. In response to 2 mg/ml of the polysaccharides the fibroblasts
displayed varied response, Figure 5 A-C. Fibroblasts from bovine 1, Figure 5A, displayed
relatively weak changes to expression of inflammatory cytokines (IL-1α, IL-1β, IL-6, IL8, TNFα) when exposed to ORC and displayed a reduction in expression of inflammatory
cytokines when exposed to chitin. Fibroblasts from bovine 2, Figure 5B, displayed a large
increase in expression of IL-6 and IL-8 in response to ORC. However, in response to chitin,
bovine 2 fibroblasts showed a weaker increase in IL-8 but a decrease in the other
inflammatory cytokines, similar to bovine 1. Bovine 3 fibroblasts showed an increase in
expression of most of the inflammatory cytokines in response to both ORC and chitin.
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Overall, chitin was more commonly associated with a lower expression of inflammatory
cytokines compared to ORC (11/ 15). On a few occasions (3/15) the change in expression
of inflammatory cytokines was very similar between the two polysaccharides. The antiinflammatory cytokine, IL-10, remained relatively unchanged for both polysaccharides.
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Figure 5. Exogenous polysaccharides alter the expression of inflammatory cytokines.
Bovine fibroblasts introduced to 2 mg/ml chitin nanofiber or ORC, increase expression of
cytokines. A-C) Change in expression of select cytokines from fibroblasts obtained from
three different bovine. D) Average change in cytokine mRNA from the three animals.
Previous works showed that an increase in the expression of toll-like receptor TLR4
is associated with exposure of keratinocytes to shrimp chitin [70]. We monitored the
changes in TLR expression in fibroblasts in response to incubation with ORC or chitin
nanofibers for 24 hours and found that both polysaccharides lead to reductions in
expression of most TLRs, with weak increases in TLR2 for cells exposed to ORC, and
TLR6 for cells exposed to chitin, Figure 6. TLR2 and 6 recognize bacterial peptidoglycan
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Figure 6. TLR expression is reduced in response to exogenous polysaccharides. TLR 4 in
particular has been associated with receptor binding of shrimp chitin to keratinocytes. Both
ORC and chitin nanofibers lower the expression of TLR 4 (along with most other TLRs),
indicating a difference in response based on source.
and lipoprotein. Both are involved in macrophage activation and are recruited to
macrophage phagosome. TLR2 forms functional pairs with TLR6 or TLR1 to stimulate
cytokine induction within macrophages. Both receptors can act independently or
cooperatively to detect bacteria and induce production of proinflammatory cytokines such
as tumor necrosis factor α [71, 72].
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Figure 7. Polysaccharides reduce expression of IL-6 and IL-8 in response to LPS. ORC
significantly lowered IL-6 expression to 1/8th the LPS control. Chitin nanofibers significantly
reduced IL-6 and IL-8 to 1/16th and 1/8th, respectively, the levels of the LPS control. * p <
0.05.
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Lipopolysaccharide, released from infectious microbes, elicits inflammatory
responses in much lower doses than the polysaccharides tested here. Chitin
oligosaccharides are reported as competitive inhibitors of this inflammatory response [73,
74]. We tested whether the long chain polysaccharides, ORC or chitin nanofibers, would
also reduce expression of inflammatory cytokines. Cells exposed to 1 µM LPS alone
caused cells to increase expression of inflammatory cytokines, IL-1α, IL-1β, IL-6, and IL8. However, LPS in the presence of the polysaccharides, administered at 2 mg/mL, caused
a general reduction in the mean levels of mRNA. There was statistically significant
reduction of the inflammatory cytokine IL-6 when ORC and chitin were present and
significant reduction of IL-8 in the presence of chitin. ORC reduced IL-6 expression by
nearly 8-fold, while chitin nanofibers reduced IL-6 and IL-8 expression by 16 and over 8fold, respectively.
ORC and ONRC are reported to reduce proliferation of fibroblasts within 24 hours
[43]. Proliferation could be a result of increased cellular mortality or lengthened cell cycle.
We tested whether the polysaccharides increased cell death by counting dead cells with a
propidium iodide staining method. After 24 hours cells were stained and counted. No
significant difference in cell mortality was measured for cells in the presence of
polysaccharides at either 2 or 5 mg/ml chitin nanofibers or ORC, compared with control
cells grown in the absence of polysaccharides, Figure 8. We conclude that the
polysaccharides do not increase cell mortality.
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Figure 8. ORC and Chitin do not increase cell mortality. There were no significant
differences between any of the treatments and the control.
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DISCUSSION
Some of the ideal characteristics of biodegradable bandages include a relatively
abundant, low cost material, that promotes wound healing while not exacerbating
inflammation or scarring. Cellulose is recognized as the most abundant organic polymer
on the planet [75] and is also capable of rapid clotting of blood [27]. However, mammals
do not possess rapid degradation pathways for raw cellulose in the absence of microbes
[76]. ORC was originally sought as a more biodegradable form of cellulose [24] possessing
negatively charged glucuronic acid residues. Nonetheless, commercially available ORC
sold for biomedical application is only partially oxidized and therefore is still composed of
raw cellulose [36, 65]. Consistent with this fact is that the ORC used for this study
contained only 38% glucuronic acid residues. The presence of cellulose, hemicellulose or
lignin in the cotton [77] could be causing the complications that result when relatively large
amounts of ORC are left inside the body after surgery.
Chitin has been described as the second most abundant organic molecule second
only to cellulose [78]. Most sources of chitin are described as highly hydrophobic and
insoluble in water and most organic solvents, making it a difficult substance to manipulate
[78]. In order to overcome this challenging chemical feature, the chitin is commonly
deacetylated and converted to the more hydrophilic chitosan for many of its commercial
applications [79, 80]. With respect to blood clotting, chitosan is inferior to both chitin and
ORC [27, 29]. The chitin nanofiber from diatoms, used for this work, appears hydrophilic
in nature, forming an extracellular mucilage that spaces the cell bodies of diatoms and
reduces the sinking velocity [81]. The diatom chitin nanofibers are highly acetylated as
reported here, Figure 3, and earlier [68]. The level of acetylation in the diatoms is similar
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to the level of chitin acetylation in the walls of different fungi [50]. The fact that
mammalian chitinases hydrolyze highly acetylated chitin of fungi is consistent with the
fact that biodegradation of chitin is much faster than biodegradation of chitosan [26, 51,
52].
Fibroblasts play a critical role in chronic inflammation and epidermal repair [62,
82, 83]. Therefore, it is important to understand the role of these polysaccharide bandages
on the fibroblasts. Both ORC and chitin caused significant, but subtle increases in the
expression of inflammatory cytokines, Figure 5. The individualized response to the
materials suggests that animal sensitivity may vary considerably based on genetics,
environmental exposure and acute health of the individual.
Bovine fibroblast TLR expression decreased when exposed to the polysaccharide
bandages, Figure 6, It is possible that the polysaccharide fibers are either indirectly
lowering expression, such as attracting and trapping stimulating factors via charge and
conformation, or that the polysaccharides are acting directly on the cells to decrease TLR
transcription. TLR2 and TLR6 expression have been shown to be modulated by cytokine
products such as IL-6, IL-10, and TNFα [84]. The detection of tri- and diacylated
lipoproteins such as hyaluronic acid fragments by both receptors, table 2, may also explain
the chitin nanofiber’s weak activation of TLR6 expression. Hyaluronic acid has highly
similar monomers to that of highly acetylated chitin. The modulation of cytokine
expression or weak structural affinity to the receptors may play a role in the expression
change of TLR2 and TLR6. This research was focused on characterization of the broader
scale application of both materials, so no definitive mechanism is described here. Future
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experiments may warrant further investigation of the signaling mechanisms altered by
these materials.
Both ORC and the chitin nanofiber bandage significantly decreased expression of
IL-6, which has been associated with fibrosis, in response to LPS. It may mimic the lower
IL-6 production found during scarless fetal wound repair [85]. This is consistent with the
fact that the chitin nanofiber bandage reduced scarring during wound repair in mice [86]
or in the ILB knockout. The chitin nanofiber bandage’s ability to lower expression of IL-8
in the presence of LPS indicates that it may be beneficial in reducing inflammation or in
deeper tissue wounds where foreign body reactions may occur to traditional bandage
materials. In the future, in vivo assays of the materials in chronic wounds would greatly
facilitate in determining the relative effect on inflammatory response and phagocyte
recruitment through chemokine production.
Solubilization of ORC leads to acidification of the surrounding fluids and may
impair cell function [43, 87]. However, in buffered medium, the change in pH due to
addition of ORC is attenuated. Under these buffered conditions cellular proliferation and
migration were still attenuated [43] leading to the conclusion that ORC may have
secondary detrimental effects on the surrounding cells. In order to test this hypothesis, we
performed a cell viability assay and determined that in 15 mM HEPES pH buffered media,
ORC did not increase mortality of bovine fibroblasts, Figure 8. In earlier studies, local pH
changes by ORC were concluded to promote the broad scale antimicrobial effects [34],
although, more recent studies with ORC aggregates provide evidence that the antimicrobial
effects may not be pH dependent [88].
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Greater clarification of the roles and interactions of skin cells and the materials we
use as therapeutics can help us develop superior treatment options for chronic skin lesions.
With increasing need for non-antibiotic solutions to microbial infections in livestock
animals, and the disruption to production that chronic wounds can inflict, research into the
application of materials like ORC and chitin is vital to stay ahead in the arms race occurring
between pathogens and their would-be treatments.

27
LITERATURE CITED
1.
2.
3.
4.
5.

6.
7.

8.
9.
10.
11.
12.
13.

14.
15.

16.
17.
18.
19.
20.

Zinicola, M., et al., Altered microbiomes in bovine digital dermatitis lesions, and the gut
as a pathogen reservoir. PLoS One, 2015. 10(3): p. e0120504.
Evans, N., R. Murray, and S. Carter, Bovine digital dermatitis: current concepts from
laboratory to farm. The Veterinary Journal, 2016. 211: p. 3-13.
Laven, R. and D. Logue, Treatment strategies for digital dermatitis for the UK. The
Veterinary Journal, 2006. 171(1): p. 79-88.
Laven, R. and M. Proven, Use of an antibiotic footbath in the treatment of bovine digital
dermatitis. Veterinary Record, 2000. 147(18): p. 503-506.
U.S. Dairy Export Council, Global Dairy Market Outlook. 2018, U.S. Dairy Export Council:
https://www.usdec.org/research-and-data/market-information/us-exportdata/historical-data.
Cha, E., et al., The cost of different types of lameness in dairy cows calculated by
dynamic programming. Preventive veterinary medicine, 2010. 97(1): p. 1-8.
Losinger, W.C., Economic impacts of reduced milk production associated with
papillomatous digital dermatitis in dairy cows in the USA. Journal of dairy research,
2006. 73(2): p. 244-256.
NASS, Milk Production Report February 2018, U.S.D.o. Agriculture, Editor. 2018.
Krull, A.C., et al., Digital dermatitis: Natural lesion progression and regression in Holstein
dairy cattle over 3 years. Journal of dairy science, 2016. 99(5): p. 3718-3731.
Scholey, R., et al., Investigating host genetic factors in bovine digital dermatitis.
Veterinary Record, 2012. 171(24): p. 624-624.
Speijers, M., et al., Effectiveness of different footbath solutions in the treatment of
digital dermatitis in dairy cows. Journal of dairy science, 2010. 93(12): p. 5782-5791.
Cheli, R. and C. Mortellaro. La dermatite digitale del bovino. in Proceedings of the 8th
International Conference on Diseases of Cattle. Piacenza, Milan, Italy. 1974.
Loureiro, M., et al., Efficacy of topical and systemic treatments with oxytetracycline for
papillomatous digital dermatitis in cows. Arquivo Brasileiro de Medicina Veterinária e
Zootecnia, 2010. 62(1): p. 13-22.
Nishikawa, A. and K. Taguchi, Healing of digital dermatitis after a single treatment with
topical oxytetracycline in 89 dairy cows. 2008, British Medical Journal Publishing Group.
J.H.Higginson Cutler, G.C., J.J. Walter, S.T. Millman, D.F. Kelton, Randomized clinical trial
of tetracycline hydrochloride bandage and paste treatments for resolution of lesions and
pain associated with digital dermatitis in dairy cattle. Journal of Dairy Science, 2013.
96(12): p. 7550-7557.
Evans, N., et al., Association between bovine digital dermatitis treponemes and a range
of ‘non-healing’bovine hoof disorders. Veterinary Record, 2011: p. vetrecc5487.
Evans, N.J., et al., Association of unique, isolated treponemes with bovine digital
dermatitis lesions. Journal of clinical microbiology, 2009. 47(3): p. 689-696.
Beninger, C., et al., Associations between digital dermatitis lesion grades in dairy cattle
and the quantities of four Treponema species. Veterinary research, 2018. 49(1): p. 111.
Evans, N.J., et al., Host and environmental reservoirs of infection for bovine digital
dermatitis treponemes. Veterinary microbiology, 2012. 156(1-2): p. 102-109.
Nielsen, M.W., et al., Potential bacterial core species associated with digital dermatitis in
cattle herds identified by molecular profiling of interdigital skin samples. Veterinary
microbiology, 2016. 186: p. 139-149.

28
21.

22.

23.

24.
25.

26.
27.

28.
29.

30.

31.
32.
33.
34.
35.
36.
37.
38.
39.

Berry, S.L., et al., Clinical, histologic, and bacteriologic findings in dairy cows with digital
dermatitis (footwarts) one month after topical treatment with lincomycin hydrochloride
or oxytetracycline hydrochloride. Journal of the American Veterinary Medical
Association, 2010. 237(5): p. 555-560.
Cutler, J.H., et al., Randomized clinical trial of tetracycline hydrochloride bandage and
paste treatments for resolution of lesions and pain associated with digital dermatitis in
dairy cattle. Journal of dairy science, 2013. 96(12): p. 7550-7557.
Shearer, J. and J. Hernandez, Efficacy of two modified nonantibiotic formulations
(Victory) for treatment of papillomatous digital dermatitis in dairy cows. Journal of Dairy
Science, 2000. 83(4): p. 741-745.
Frantz, V.K., Absorbable cotton, paper and gauze - (oxidized cellulose). Annals of Surgery,
1943. 118(1): p. 116-126.
Noh, H.K., et al., Electrospinning of chitin nanofibers: Degradation behavior and cellular
response to normal human keratinocytes and fibroblasts. Biomaterials, 2006. 27(21): p.
3934-3944.
Lim, S.M., et al., In vitro and in vivo degradation behavior of acetylated chitosan porous
beads. Journal of Biomaterials Science Polymer Edition, 2008. 19(4): p. 453-466.
Rembe, J.-D., et al., Comparison of hemostatic dressings for superficial wounds using a
new spectrophotometric coagulation assay. Journal of Translational Medicine, 2015.
13(1): p. 375.
Chiara, O., et al., A systematic review on the use of topical hemostats in trauma and
emergency surgery. BMC Surgery, 2018. 18(1): p. 68.
Fischer, T.H., et al., Hemostatic properties of glucosamine-based materials. Journal of
Biomedical Materials Research Part A: An official journal of the Society for Biomaterials,
2007. 80(1): p. 167-174.
Masci, E., G. Faillace, and M. Longoni, Use of oxidized regenerated cellulose to acheive
hemostasis during laparoscopic cholecystectomy: a retrospective cohort analysis. BMC
Research Notes, 2018. 11(1): p. 239.
Fulco, I., et al., Poly-N-acetyl glucosamine nanofibers for negative-pressure wound
therapies. Wound Repair and Regeneration, 2015. 23: p. 197-202.
Moura, L.I.F., et al., Recent advances on the development of wound dressings for
diabetic foot ulcer treatment-A review. Acta Biomaterialia, 2013. 9: p. 7093-7114.
Lewis, K.M., et al., Comparison of regenerated and non-regenerated oxidized cellulose
hemostatic agents. European Surgery, 2013. 45(4): p. 213-220.
Spangler, D., et al., In vitro antimicrobial activity of oxidized regenerated cellulose
against antibiotic-resistant microorganisms. Surgical Infections, 2003. 4(3): p. 255-262.
Dineen, P., The effect of oxidized regenerated cellulose on experimental infected
splenotomies. Journal of Surgical Research, 1977. 23(2): p. 114-116.
Dimitrijevich, S.D., M. Tatarko, and R.W. Gracy, Biodegradation of oxidized regenerated
cellulose. Carbohydrate Research, 1990. 195: p. 247-256.
Dimitrijevich, S.D., et al., In vivo degradation of oxidized, regenerated cellulose.
Carbohydrate Research, 1990. 198: p. 331-341.
Wu, S., et al., Oxidized regenerated cellulose/collagen dressings: review of evidence and
recommendations. Advances in Skin & Wound Care, 2017. 30(11): p. S1.
Wang, H. and P. Chen, Surgicel® (oxidized regenerated cellulose) granuloma mimicking
local recurrent gastrointestinal stromal tumor: A case report. Oncology Letters, 2013.
5(5): p. 1497-1500.

29
40.

41.

42.

43.
44.
45.
46.

47.
48.
49.
50.
51.

52.
53.
54.
55.

56.
57.
58.

59.

Haidari, T.A., et al., Oxidized resorbable cellulose (Gelita-cel) causing foreign body
reaction in mediastinum. Interactive Cardiovascular and Thoracic Surgery, 2018. 27(6):
p. 881-883.
Piozzi, G.N., et al., Practical suggestions for prevention of complications arising from
oxidized cellulose retention: A case report and review of the literature. American Journal
of Case Reports, 2018. 19: p. 812-819.
Keshavarzi, S., et al., Clinical experience with the surgicel family of absorbable hemostats
(oxidized regenerated cellulose) in neurosurgical applications: a review. Wounds 2013.
25(6): p. 160-167.
Wagenhäuser, M.U., et al., Oxidized (non)-regenerated cellulose affects fundamental
cellular processes of wound healing. Scientific Reports, 2016. 6(32238).
Dowling, M.B., et al., A self-assembling hydrophobically modified chitosan capable of
reversible hemostatic action. Biomaterials, 2011. 32: p. 3351-3357.
Benhabiles, M.S., et al., Antibacterial activity of chitin, chitosan and its oligomers
prepared from shrimp shell waste. Food Hydrocolloids, 2012. 29: p. 48-56.
Seyfarth, F., et al., Antifungal effect of high- and low-molecular-weight chitosan
hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-Dglucosamine against Candida albicans, Candida krusei and Candida glabrata.
International Journal of PHarmaceutics, 2008. 353: p. 139-148.
Raafat, D. and H.-G. Sahl, Chitosan and its antimicrobial potential - a critical literature
survey. Microbial Biotechnology, 2009. 2(2): p. 186-201.
Lindner, H.B., et al., Anti-bacterial effects of poly-N-acetyl-glucosamine nanofibers in
cutaneous wound healing: Requirement for Akt1. Plos One, 2011. 6(4): p. e18996.
Muzzarelli, R.A.A., Human enzymatic activities related to the therapeutic administration
of chitin derivatives. Cellular and Molecular Life Sciences, 1997. 53: p. 131-140.
Wagener, J., et al., Fungal chitin dampens inflammation through IL-10 induction
mediated by NOD2 and TLR9 Activation. PLoS Pathogens, 2014. 10(4): p. e1004050.
Yang, Y.M., et al., The controlling biodegradation of chitosan fibers by N-acetylation in
vitro and in vivo. Journal of Materials Science: Materials in Medicine, 2007. 18(11): p.
2117-2121.
Tomihata, K. and Y. Ikada, In vitro and in vivo degradation of films of chitin and its
deacetylated derivatives. Biomaterials, 1997. 18: p. 567-575.
Da Silva, C.A., et al., Chitin is a size-dependent regulator of macrophage TNF and IL-10
production. The Journal of Immunology, 2009. 182: p. 3573-3582.
Da Silva, C.A., et al., TLR-2 and IL-17A in chitin-induced macrophage activation and acute
inlfammation. The Journal of Immunology, 2008. 181: p. 4279-4286.
Brandt, C. and B.K. Pedersen, The role of exercise-induced myokines in muscle
homeostasis and the defense against chronic diseases. BioMed Research International,
2010. 2010.
Arend, W.P., et al., Interleukin-1 receptor antagonist: role in biology. Annual review of
immunology, 1998. 16(1): p. 27-55.
Kawai, T. and S. Akira, Signaling to NF-κB by Toll-like receptors. Trends in molecular
medicine, 2007. 13(11): p. 460-469.
Smith, E.M., et al., Corticotropin releasing factor (CRF) activation of NF-κB-directed
transcription in leukocytes. Cellular and molecular neurobiology, 2006. 26(4-6): p. 10191034.
Frykberg, R.G. and J. Banks, Challenges in the treatment of chronic wounds. Advances in
Wound Care, 2015. 4(9): p. 560-582.

30
60.
61.
62.

63.

64.

65.

66.
67.
68.

69.
70.
71.

72.

73.
74.

75.
76.
77.
78.

Schäfer, M. and S. Werner, Oxidative stress in normal and impaired wound repair.
Pharmacological Research, 2008. 58: p. 165-171.
Wilson-Welder, J.H., D.P. Alt, and J.E. Nally, Digital dermatitis in cattle: current bacterial
and immunological findings. Animals, 2015. 5(1114-1135).
Evans, N.J., et al., Differential inflammatory responses of bovine foot skin fibroblasts and
keratinocytes to digital dermatitis treponemes. Veterinary Immunology and
Immunopathology, 2014. 161: p. 12-20.
Vournakis, J.N., et al., Isolation, purification and characterization of poly-N-acetyl
glucosamine use as a hemostatic agent. Journal of Trauma and Acute Care Surgery,
2004. 57(1): p. S2-S6.
Takanashi, N., et al., Advanced application of bovine intestinal epithelial cell line for
evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia
coli-mediated inflammation. BMC microbiology, 2013. 13(1): p. 54.
Kumar, V. and T. Tang, Analysis of carboxyl content in oxidized celluloses by solid-state
13
C CP/MAS NMR spectroscopy. International Journal of Pharmaceutics, 1999. 184: p.
219-226.
Ottøy, M.H., K.M. Vårum, and O. Smidsrød, Compositional heterogeneity of
heterogeneously deacetylated chitosans. Carbohydrate Polymers, 1996. 29(1): p. 17-24.
Ottøy, M.H., et al., Preparative and analytical size-exclusion chromatography of
chitosans. Carbohydrate Polymers, 1996. 31(4): p. 253-261.
Vournakis, J.N., et al., Methods and compositions for poly-β-1→4-N-acetylglucosamine
cell therapy system, U. States, Editor. 1999, Marine Polymers Technologies: United
States.
Kubota, C., et al., Six cloned calves produced from adult fibroblast cells after long-term
culture. Proceedings of the National Academy of Sciences, 2000. 97(3): p. 990-995.
Koller, B., et al., Chitin modulates innate immune repsonses of keratinocytes. Plos One,
2011. 6(2): p. e16594.
de Almeida, L.A., et al., Toll-like receptor 6 plays an important role in host innate
resistance to Brucella abortus infection in mice. Infection and immunity, 2013. 81(5): p.
1654-1662.
Ozinsky, A., et al., The repertoire for pattern recognition of pathogens by the innate
immune system is defined by cooperation between toll-like receptors. Proceedings of the
National Academy of Sciences, 2000. 97(25): p. 13766-13771.
Lee, P.N., P. Callaerts, and H.G. de Couet, The embryonic development of the Hawaiian
bobtail squid. Cold Spring Harbor Protocols, 2009. 11: p. pdb.ip77.
Qiao, Y., X.-F. Bai, and Y.-G. Du, Chitosan oligosaccharides protect mice from LPS
challenge by attenuation of inflammation and oxidative stress. International
immunopharmacology, 2011. 11(1): p. 121-127.
Klemm, D., et al., Cellulose: fascinating biopolymer and sustainable raw material.
Angewandte chemie international edition, 2005. 44(22): p. 3358-3393.
Leschine, S.B., Cellulose degradation in anaerobic environments. Annual Reviews, 1995.
49: p. 399-426.
de Morais Teixeira, E., et al., Cellulose nanofibers from white and naturally colored
cotton fibers. Cellulose, 2010. 17(3): p. 595-606.
Kumar, M.N.V.R., A review of chitin and chitosan applications. Reactive and Functional
Polymers, 2000. 46(1): p. 1-27.

31
79.

80.

81.
82.
83.
84.

85.
86.

87.

88.

Fernandez, J.G. and D.E. Ingber, Manufacturing of large-scale functional objects using
biodegradable chitosan bioplastic. Macromolecular Materials and Engineering, 2014.
299: p. 932-938.
Bellich, B., et al., "The Good, the Bad and the Ugly" of Chitosans. Marine Drugs, 2016.
14(5): p. 99
Walsby, A.E. and A. Xypolita, The form resistance of chitan fibres attached to the cells of
Thalassiosira fluviatilis Hustedt. British Phycological Journal, 1977. 12(3): p. 215-223.
Aziz, A., et al., The cumulative and sublethal effects of turbulence on erythrocytes in a
stirred-tank model. Annals of Biomedical Engineering, 2007. 35: p. 2108-2120.
Buckley, C.D., Why does chronic inflammation persist: an unexpected role for fibroblasts.
Immunology Letters, 2011. 138: p. 12-14.
Zarember, K.A. and P.J. Godowski, Tissue expression of human Toll-like receptors and
differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes,
their products, and cytokines. The journal of immunology, 2002. 168(2): p. 554-561.
Liechty, K.W., N.S. Adzick, and T.M. Crombleholme, Diminished interleukin 6 (IL-6)
production during scarless human fetal wound repair. Cytokine, 2000. 12(6): p. 671-676.
Lindner, H.B., et al., pGlcNAc nanofiber treatment of cutaneous wounds stimulate
increased tensile strength and reduced scarring via activation of Akt1. PloS One, 2015.
10(5): p. e0127876.
Kunio, N.R. and M.A. Schreiber, Topical hemostatic agents, in Consultative hemostasis
and thrombosis 3rd edition, C.S. Kitchens, C.M. Kessler, and B.A. Konkle, Editors. 2013,
Elsevier Inc.: Philadelphia, PA. p. 538-545.
Wang, A.Y., et al., Absorbable hemostatic aggregates. ACS Biomaterials Science and
Engineering, 2017. 3: p. 3675-3686.

